NBY - NovaBay GAAP EPS of -$0.10 revenue of $3.83M November, 14 2022 04:13 PM NovaBay Pharmaceuticals Inc. NovaBay press release ( NYSE: NBY ): Q3 GAAP EPS of -$0.10. Revenue of $3.83M (+68.7% Y/Y) NovaBay had cash and cash equivalents of $3.9 million as of September 30, 2022, compared with $7.5 million as of December 31, 2021. For further details see: NovaBay GAAP EPS of -$0.10, revenue of $3.83M